Text
Lung cancer does not always follow the story people expect.
Screening is not about expecting bad news. It is about reducing uncertainty, and giving you and your clinician more options while there are more options to have.
Bryan LeBlanc
Family experience
Twenty years later, the experience still shapes the way Bryan thinks about early detection.
His story is a reminder that behind every diagnosis is a patient, a family and a period of life that can change very quickly when cancer is found late.
Earlier detection matters because it can create more opportunity to act before those options begin to narrow.
As we continue sharing perspectives, we want to bring forward the experiences that explain why this work matters to the people behind it.
This is Bryan’s.
Originally shared on LinkedIn
Join the conversation and see how others have responded.
Advancing infrared applications for earlier detection — beginning with lung cancer.
AIR-DS is a UKCA marked in vitro diagnostic medical device, developed in accordance with IEC 62304 and under an ISO 13485 certified quality management system. In the US, a CLIA certified laboratory will offer a laboratory developed test (LDT) with AIR-DS Lung Test. It has not been cleared or approved by the FDA. Information on this website is provided for educational and informational purposes and should not be interpreted as medical advice.